Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma by Ito, Y et al.
Carcinoma progression and prognosis can be evaluated by many
parameters. The simplest and most often used is the cell prolifer-
ating activity of the main tumours. In particular, Ki-67 is
expressed by all cells except when they are at the G0 phase (Sasaki
et al, 1987). Therefore, Ki-67 expression in carcinomas has been
intensively investigated, and the Ki-67-positive cell rate has been
shown to be significantly related to clinicopathological features
and even survival time in cases of carcinoma of several organs
(Avali-Lundqvist et al, 1997; Jansson et al, 1997; Molino et al,
1997; Victorzon et al, 1997; Beer et al, 1998; Komaki et al, 1998;
Masuda et al, 1998). Another important phenomenon for evalu-
ating the activity of carcinoma progression is cell death. In partic-
ular, apoptosis or programmed cell death, in carcinoma has been
studied actively from various aspects since it became clear that
carcinoma cells as well as normal cells can die with apoptosis.
Previous studies have shown a high percentage of apoptotic cells
correlated with high proliferating activity and/or shortened
survival in carcinoma of bladder, uterus, ovary, lung, endometrium
and prostate (Lipponen et al, 1994; Vasalainen et al, 1994; Heatley
1995; Tormanen et al, 1995; Todd et al, 1996; Yamasaki et al,
1997; Komaki et al, 1998), although there was one contrary result
reported for colorectal carcinoma (Sugamura et al, 1998).
In the present study, we investigated both the Ki-67-positive cell
rate and the morphologically apoptotic cell rate in hepatocellular
carcinoma (HCC). As distant or lymph node metastases are
usually not observed with HCC, we thought it very important to
study the cell proliferation and cell death of the main tumour in
order to evaluate the biological aggressiveness of this carcinoma.
MATERIALS AND METHODS
Tissue specimens
Ten per cent buffered formalin-fixed, paraffin-embedded blocks of
HCC were prepared from 76 patients (65 males and 11 females:
age 61.5 ± 9.9 years) who had undergone curative surgery for
HCC diagnosed by computerized tomography, angiography and
preoperative and intraoperative ultrasonography. Informed
consent was obtained from each patient.
Immunohistochemistry for Ki-67 and evaluation of
Ki-67-labelling index
Immunohistochemical study was performed using the avidin–
biotin complex (ABC) method. Briefly, 4-mm slices of tissue
section were deparaffinized and endogenous peroxidase activity
was blocked with 0.3% hydrogen peroxide and 0.1% sodium azide
in distilled water for 15 min. The sections were then incubated
with 0.03 mol l–1 citrate buffer (pH 6.0) and heated to 121°C for 20
min in a pressure cooker. After three rinsings in phosphate-
buffered saline (PBS) pH 7.2, 10% bovine serum (Wako, Osaka,
Japan) was applied for 10 min to block the non-specific reaction.
The sections were incubated with anti-Ki-67 monoclonal antibody
(clone MIB-1, Ylem, Rome, Italy) at the concentration of 1:50 for
60 min at room temperature. After rinsing in PBS, they were
treated with biotinylated sheep anti-mouse IgG (Amersham,
London, UK) at the concentration of 1:50 for 15 min. Again, after
rinsing in PBS, the sections were reacted with the avidin–biotin
peroxidase complex (Dako, Denmark) at the concentration of
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Osaka 565, Japan1:300 for 15 min. The peroxidase reaction was visualized by
incubating the sections with 0.02% 3,3¢-diaminobenzidine tetrahy-
drochloride in 0.05 M Tris buffer (pH 7.6) with 0.01% hydrogen
peroxide for 3 min. The sections were counterstained with haema-
toxylin. Sections for negative control were prepared by using
normal mouse serum instead of primary antibody.
We counted Ki-67-positive cells by monitoring at least 500
HCC cells from at least five randomly selected fields. The
percentage of Ki-67-positive cells was defined as the Ki-67-
labelling index (LI).
Evaluation of apoptotic index
We observed each section stained with haematoxylin and eosin
(H&E), and regarded the cells as morphologically apoptotic when
they satisfied two of the conditions by Kerr et al: eosinophilic
cytoplasm, shrinkage of cell and pyknosis, and/or fragmentation of
the nucleus (Kerr et al, 1972; Wyllie et al, 1980). We counted
morphologically apoptotic cells by monitoring at least 1000 HCC
cells from at least ten randomly selected fields. The number of
apoptotic cells per 1000 cells was defined as the apoptotic index
(AI).
Survival data
Disease-free survival (DFS) of the 76 patients was followed from
6 to 83 months (mean 22.5 ± 17.1 months). Postoperative DFS
curves were constructed by the Kaplan–Meier method.
Statistical analyses
Values were expressed as mean ± s.e.m. The c2 test and Student’s t-
test were adopted for analyses about the indices and clinicopatho-
logical parameters. The relationship between Ki-67 LI and AI was
analysed by Spearman’s rank correlation coefficient. Univariate
DFS data were analysed by the log-rank test. For multivariate
analyses, we used the Cox proportional hazard model. All P-values
less than 0.05 were considered to be statistically significant.
RESULTS
We investigated Ki-67 LI and AI of HCC and their relationship
with various backgrounds and clinicopathological features such as
age, gender, viral infection, liver cirrhosis, tumour size, stage,
degrees of differentiation, capsule formation, extracapsular inva-
sion, septal formation, portal invasion and intrahepatic metastasis.
Various pathological classifications including degrees of differen-
tiation and stage were based on the classification of the Liver
Cancer Group of Japan (1992).
Ki-67 LI of HCC in our series ranged from 3.0 to 81.5 (mean
± s.e.m., 29.1 ± 19.9). The indices were significantly higher in
cases of poor differentiation (P < 0.0001), stage III (P = 0.0384),
with portal invasion (P = 0.0001) and with intrahepatic metastasis
(P = 0.0274) (Table 1). The number of cases with different degrees
of differentiation, stage, portal invasion and intrahepatic metas-
tasis are also noted in Table 1. The presence of portal invasion and
intrahepatic metastasis were histologically determined.
Figure 1 shows a typical profile of morphologically apoptotic
HCC cells in the H&E section. AI ranged from 4.5 to 44.5
(mean ± s.e.m., 17.2 ± 10.2) and a positive correlation was
strongly observed in our cases between Ki-67 LI and AI
(P < 0.0001) by Spearman’s rank correlation coefficient. AI also
748 Y Ito et al
British Journal of Cancer (1999) 81(4), 747–751 © 1999 Cancer Research Campaign
Table 1 Relationship between clinicopathological parameters and Ki-67 LI
and AI in 76 HCC cases
Ki-67 LI AI
Tumour differentiation
Well or moderate (n = 55) 21.8 ± 16.8 13.4 ± 6.6
Poor (n = 21) 47.7 ± 14.4 25.9 ± 10.9
P < 0.0001 P < 0.0001
Stage
I or II (n = 54) 26.0 ± 19.4 14.7 ± 7.3
III (n = 22) 36.3 ± 19.3 22.0 ± 12.9
P = 0.0384 P = 0.0023
Portal invasion
With (n = 24) 41.5 ± 20.2 21.7 ± 12.6
Without (n = 52) 23.2 ± 16.9 14.6 ± 7.3
P = 0.0001 P = 0.0025
Intrahepatic metastasis
With (n = 14) 39.4 ± 19.3 22.3 ± 11.5
Without (n = 62) 26.6 ± 19.3 15.6 ± 9.0
P = 0.0274 P = 0.0192
Table 2 Univariate and multivariate analysis for disease-free survival
Univariate Multivariate
Tumour differentiation 0.0141 0.8757 0.8536 – –
(well, moderate vs poor)
Tumour size 0.0148 0.4509 0.2727 – –
(5 cm or larger vs
smaller than 5 cm)
Portal invasion (+ vs –) 0.0483 0.1929 0.0803 – –
Intrahepatic metastasis 0.0003 0.0346 0.1011 – –
(+ vs –)
Stage (I, II vs III) 0.0005 – – 0.0072 0.0056
Ki-67 LI (20 or larger vs 0.0001 0.0088 – 0.0049 –
smaller than 20)
AI (15 or larger vs smaller
than 15) 0.0005 – 0.0208 – 0.0016
Figure 1 Typical profile of morphologically apoptotic HCC cell in a
haematoxylin–eosin-stained section (arrow). Scale bar: 20 mmwas significantly higher in cases of poor differentiation
(P < 0.0001), stage III (P = 0.0023), with portal invasion
(P = 0.0025) and with intrahepatic metastasis (P = 0.0192) as
summarized in Table 1.
We then investigated the prognostic significance for DFS of each
factor. The patients with Ki-67 LI higher than 20 and those with AI
higher than 15 showed poorer outcomes for DFS (P = 0.0001 and
P = 0.0005 respectively) by univariate analysis (Figure 2 A, B). We
also performed multivariate analysis using the Cox proportional
hazard model for each factor (Table 2) and found that, in addition to
the clinical stage classification, Ki-67 LI and AI both served as
independent prognostic factors for DFS of HCC patients after cura-
tive surgery. We performed the analysis by adding both Ki-67 and
AI, but no informative results could be obtained probably because
there is too much correlation between these two parameters.
DISCUSSION
This study made it clear that Ki-67 LI is significantly higher in
HCC cases with shorter DFS, as well as with biologically aggres-
sive features such as poor differentiation, portal invasion, intra-
hepatic metastasis and advanced stages. Therefore, Ki-67 LI
Ki-67 and apoptosis in hepatocellular carcinoma 749
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Figure 2 (A) Disease-free survival curve of patients with Ki-67 LI ³ 20 and < 20 following curative surgery. (B) Disease-free survival curve of patients with
AI ³ 15 and < 15 following curative surgeryshould be a useful marker for evaluating the progressive activity
and predicting DFS in HCC cases. Other groups have studied this.
Three European groups could not establish the prognostic value
for Ki-67 LI, probably because of the small number of cases in
their studies (Colleoni et al, 1995; Faccioli et al, 1996; Nolte et al,
1998). Ng et al (1995) demonstrated that Ki-67 LI was correlated
with carcinoma differentiation and DFS solely by univariate
analysis. Although the antibody clone that they used was the same
as ours, they heated the sections in citrate buffer in a microwave
oven for antigen retrieval. This may have led to the results which
differ from ours. We used a pressure cooker instead, because it can
heat the sections more uniformly under higher temperature. In
fact, for representative sections, we tried both methods and
obtained higher Ki-67 LI when the pressure cooker was used (data
not shown). The most recent study demonstrated the prognostic
value of Ki-67 LI in HCC by multivariate analysis (King et al,
1998). However, it is strange that they could not establish any
correlation between the LI and clinicopathological features,
because cell-proliferating activity should contribute greatly to the
biological aggressiveness of carcinoma. One possible reason for
differing results is that they adopted a different clone from MIB-1
and used frozen sections.
We found a striking correlation between Ki-67 LI and AI
(P < 0.0001), as well as positive relationships of AI with rapidly
growing characters and even shorter DFS. These findings imply that
the clinical significance of Ki-67 and AI in HCC are very similar,
although they reflect two opposite phenomena: cell proliferation and
cell death. Some groups have studied both apoptosis and cell pro-
liferation in HCC (Hino et al, 1996; Soini et al, 1996; Zhao et al,
1997). Although these factors tended to show correlation in two
studies (Hino et al, 1996; Zhao et al, 1997) using different markers,
none of the reports could clarify the prognostic value of AI,
probably because of the small number of cases examined.
Apoptosis in carcinoma is known to be induced by some kind of
attack against carcinoma, such as by T lymphocytes by means of
Fas ligand (Fas L) which binds to Fas located on the surface
of carcinoma cells and turns them apoptotic (Itoh et al, 1991).
However, Fas expression in HCC is reduced in biologically
aggressive cases, such as poorly differentiated carcinoma (Ito et al,
1998), indicating a lesser likelihood of death by apoptosis by the
Fas–Fas L pathway. Therefore, we hypothesize that there is
another type of mechanism inducing apoptosis as a concomitant
phenomenon to rapid growth and turnover of carcinoma cells.
Fukuda et al (1993) demonstrated that apoptosis might be induced
by, for example, autoregulation against the expanding population
of carcinoma cells and/or cellular injury caused by hypoxia and
nutrient deficiency (Fukuda et al, 1993). Although further studies
are necessary, their findings may help to interpret, to some extent,
our results about AI in HCC.
For detection of apoptotic cells, in-situ labelling of fragmented
DNA is also widely employed (Gavrieli et al, 1992; Anasari et al,
1993; Gorczyca et al, 1993; Wijsman et al, 1993). However,
previous studies reported that apoptotic cells could not be
completely identified even by this method (Anasari et al, 1993;
Gorczyca et al, 1993; Wijsman et al, 1993). Accordingly, morpho-
logical assessment of apoptosis using H&E-stained sections
should still be very useful, especially in clinical fields, as the
simplest method for detecting apoptotic cells (Gaffney et al, 1994;
Heatley et al, 1995).
In summary, both Ki-67 LI and AI strongly reflect the biological
characteristics of HCC and can be used to predict the DFS of HCC
patients. As AI can be easily determined from H&E-stained
sections, it should be extremely useful for screening the large
number of HCC cases from various hospitals with various condi-
tions of fixation.
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